IT1254996B - Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione - Google Patents

Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione

Info

Publication number
IT1254996B
IT1254996B ITMI921559A ITMI921559A IT1254996B IT 1254996 B IT1254996 B IT 1254996B IT MI921559 A ITMI921559 A IT MI921559A IT MI921559 A ITMI921559 A IT MI921559A IT 1254996 B IT1254996 B IT 1254996B
Authority
IT
Italy
Prior art keywords
eseroline
esters
anticolinesterasics
alkylcarbammic
amino
Prior art date
Application number
ITMI921559A
Other languages
English (en)
Inventor
Mario Brufani
Sperandina Lappa
Pier Giuseppe Pagella
Stefano Maiorana
Donata Marchesini
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of ITMI921559A0 publication Critical patent/ITMI921559A0/it
Priority to ITMI921559A priority Critical patent/IT1254996B/it
Priority to DE69320705T priority patent/DE69320705D1/de
Priority to AT93109932T priority patent/ATE170522T1/de
Priority to EP93109932A priority patent/EP0575954B1/en
Priority to US08/079,921 priority patent/US5302593A/en
Priority to JP5175912A priority patent/JPH06206882A/ja
Priority to CA002099648A priority patent/CA2099648A1/en
Priority to KR1019930011626A priority patent/KR940005627A/ko
Publication of ITMI921559A1 publication Critical patent/ITMI921559A1/it
Priority to US08/177,325 priority patent/US5424451A/en
Application granted granted Critical
Publication of IT1254996B publication Critical patent/IT1254996B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici, avente formula generale (I) (FORMULA I) R è un'ammina scelta nel gruppo costituito da (FORMULA II) ed n, R1, R2, R3 ed R4 hanno il significato definito nel testo.
ITMI921559A 1992-06-25 1992-06-25 Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione IT1254996B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI921559A IT1254996B (it) 1992-06-25 1992-06-25 Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
DE69320705T DE69320705D1 (de) 1992-06-25 1993-06-22 Aminoalkylcarbamatester von Eserolin verwendbar als Inhibitoren von Cholinesteraseaktivität und Verfahren zu deren Herstellung
AT93109932T ATE170522T1 (de) 1992-06-25 1993-06-22 Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung
EP93109932A EP0575954B1 (en) 1992-06-25 1993-06-22 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process
US08/079,921 US5302593A (en) 1992-06-25 1993-06-23 Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors
JP5175912A JPH06206882A (ja) 1992-06-25 1993-06-24 コリンエステラーゼ活性インヒビターとしての使用に適したエセロリンのアミノアルキルカルバミンエステル及びその調製法
CA002099648A CA2099648A1 (en) 1992-06-25 1993-06-24 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase activity inhibitors and relative preparation process
KR1019930011626A KR940005627A (ko) 1992-06-25 1993-06-24 콜린에스테라제 활성 저해제로서 적합한 에제롤린의 아미노알킬카르밤산 에스테르 및 이의 제조방법
US08/177,325 US5424451A (en) 1992-06-25 1994-01-04 Process for preparing aminoalkylcarbamic esters of eseroline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921559A IT1254996B (it) 1992-06-25 1992-06-25 Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione

Publications (3)

Publication Number Publication Date
ITMI921559A0 ITMI921559A0 (it) 1992-06-25
ITMI921559A1 ITMI921559A1 (it) 1993-12-25
IT1254996B true IT1254996B (it) 1995-10-11

Family

ID=11363576

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921559A IT1254996B (it) 1992-06-25 1992-06-25 Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione

Country Status (8)

Country Link
US (2) US5302593A (it)
EP (1) EP0575954B1 (it)
JP (1) JPH06206882A (it)
KR (1) KR940005627A (it)
AT (1) ATE170522T1 (it)
CA (1) CA2099648A1 (it)
DE (1) DE69320705D1 (it)
IT (1) IT1254996B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133444A (en) 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
IT1271679B (it) * 1994-07-18 1997-06-04 Mediolanum Farmaceutici Srl Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
JP2001518054A (ja) * 1995-06-07 2001-10-09 パーセプティブ バイオシステムズ，インコーポレーテッド Ｐｎａ−ｄｎａキメラと、このキメラ合成用のｐｎａシントン
US5952506A (en) * 1997-04-24 1999-09-14 American Home Products Corporation Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
CA2789014C (en) * 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
EP0513703A3 (en) * 1991-05-13 1993-01-13 Magis Farmaceutici S.P.A. Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle

Also Published As

Publication number Publication date
ITMI921559A0 (it) 1992-06-25
ITMI921559A1 (it) 1993-12-25
KR940005627A (ko) 1994-03-22
CA2099648A1 (en) 1993-12-26
DE69320705D1 (de) 1998-10-08
EP0575954A1 (en) 1993-12-29
US5424451A (en) 1995-06-13
ATE170522T1 (de) 1998-09-15
US5302593A (en) 1994-04-12
EP0575954B1 (en) 1998-09-02
JPH06206882A (ja) 1994-07-26

Similar Documents

Publication Publication Date Title
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
ATE181551T1 (de) Taxol-derivate
DK0749432T3 (da) 9-deoxotaxan-forbindelser
DK0667852T3 (da) Hidtil ukendte 3,3-diphenylpropylaminer samt deres anvendelse og fremstilling
CA2174494A1 (en) Benzofurans
ES8306093A1 (es) Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos.
AU589501B2 (en) Fuel composition
IT1254996B (it) Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
BR1100061A (pt) Composto, processo para a preparação do mesmo, composição e uso dos mesmos
CO4700452A1 (es) Derivados de indol
AU7736191A (en) Oxazolidinones
UA8028A1 (uk) Спосіб отримання похідних птерідіна
ATE276274T1 (de) Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament
DK0649405T3 (da) 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE69619259D1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
IT1271679B (it) Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
GB9426090D0 (en) Pharmaceutical compounds
DK0532530T3 (da) Derivater af 6-amino-octahydroindolizintriol
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
GB2245566A (en) Carbamoyl derivatives of alkanolamines and antistress-action agent for plant-growth regulation based thereon

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970627